Aimed to compare IOTA (International ovarian tumor analysis) and RMI3 (Risk of malignancy index3) in evaluation of adnexal masses for prediction of ovarian malignancy in premenopausal and postmenopausal females

被引:0
|
作者
Pandey, Shikha [1 ]
Singh, Sapna [2 ]
Lal, Pavika [1 ]
Gupta, Renu [1 ]
Dwivedi, Divya [1 ]
Yadav, Rashmi [1 ]
机构
[1] GSVM Med Coll, Dept Obstet & Gynaecol, Kanpur, UP, India
[2] GMC Kannauj, Dept Obstet & Gynaecol, Kannauj, UP, India
关键词
Adnexal masses; International ovarian tumor analysis (IOTA); Risk of malignancy INDEX 3 (RMI3); Serum CA125; Ovarian cancer; Fine needle aspiration cytology; Histopathology;
D O I
10.1007/s40944-024-00931-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BackgroundOvarian cancer being the most lethal gynecological cancer still poses a diagnostic challenge due to non-specific findings on imaging modalities which may mimic benign pathology. The study aimed to compare the diagnostic performance of RMI3 (Risk of malignancy index) and IOTA (International ovarian tumor analysis) score in prediction of ovarian malignancy in both post- and premenopausal women.Materials and MethodsThis prospective comparative study (June 2022-June 2024) done in Department of Obstetrics and Gynaecology in collaboration with Department of Pathology and Radiodiagnosis, GSVM, Medical College, Kanpur. The study was carried out on 68 participants presenting with newly diagnosed cases of adnexal masses, and patients were divided into two groups based on their menopausal status. Each group underwent through USG color Doppler of whole abdomen and pelvis alone with serum CA125 levels. Risk assessment was done by IOTA and RMI3, and results were compared with histopathology report/or USG-guided fine needle aspiration cytology (gold standard).ResultsThe study found that malignant ovarian cancer was reported in 11.4% patients of premenopausal and 66.7% patients of postmenopausal age group. Also the IOTA Score had better performance in both pre- and postmenopausal age group with overall sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) being 100%, 97.6%, 96.3% and 100%, respectively, as compared to RMI3 which had sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 92.3%, 95.2%, 92.3% and 95.2%, respectively.ConclusionBoth IOTA and RMI3 demonstrated good diagnostic accuracy for preoperative workup of adnexal masses in prediction of ovarian malignancies, but IOTA stood out as a superior alternative due to its simplicity, ease of use, and cost effectiveness.
引用
收藏
页数:6
相关论文
共 21 条
  • [1] Preoperative Evaluation of Risk of Ovarian Malignancy Algorithm Index in Prediction of Malignancy of Adnexal Masses
    Farzaneh, Farah
    Honarvar, Zahra
    Yaraghi, Mansoore
    Yaseri, Mehdi
    Arab, Maliheh
    Hosseini, Maryamsadat
    Ashrafgangoi, Tahereh
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (06)
  • [2] COMPARISON OF ROMA (RISK OF OVARIAN MALIGNANCY ALGORITHM), RMI (RISK OF MALIGNANCY INDEX) AND OTI (OVARIAN TUMOR INDEX) IN PATIENTS WITH ADNEXAL MASS
    Ikiz, N.
    Guvenal, T.
    Taneli, F.
    Koyuncu, F. M.
    Kandiloglu, A. R.
    Bilge, S.
    Koltan, S. O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [3] Comparison of Simple Ultrasound Rules by International Ovarian Tumor Analysis (IOTA) with RMI-1 and RMI-4 (Risk of Malignancy Index) in Preoperative Differentiation of Benign and Malignant Adnexal Masses
    Dewangan, Shalinee
    Gupta, Sonal
    Chawla, Indu
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2024, 74 (02): : 158 - 164
  • [4] Comparison of Simple Ultrasound Rules by International Ovarian Tumor Analysis (IOTA) with RMI-1 and RMI-4 (Risk of Malignancy Index) in Preoperative Differentiation of Benign and Malignant Adnexal Masses
    Shalinee Dewangan
    Sonal Gupta
    Indu Chawla
    The Journal of Obstetrics and Gynecology of India, 2024, 74 : 158 - 164
  • [5] The International Ovarian Tumor Analysis Assessment of Different Neoplasias in the Adnexa (IOTA-ADNEX) Model Assessment for Risk of Ovarian Malignancy in Adnexal Masses
    Cherukuri, Srinidhi
    Jajoo, Shubhada
    Dewani, Deepika
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [6] Predicting malignancy in adnexal masses by the international ovarian tumor analysis-simple rules
    Solanki, Vrushti
    Singh, Pratibha
    Sharma, Charu
    Ghuman, Navdeep
    Sureka, Binit
    Shekhar, Shashank
    Gothwal, Meenakshi
    Yadav, Garima
    JOURNAL OF MID-LIFE HEALTH, 2020, 11 (04) : 217 - 223
  • [7] Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses
    Van Gorp, Toon
    Veldman, Joan
    Van Calster, Ben
    Cadron, Isabelle
    Leunen, Karin
    Amant, Frederic
    Timmerman, Dirk
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (11) : 1649 - 1656
  • [8] Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
    Timmerman, Dirk
    Van Calster, Ben
    Testa, Antonia
    Savelli, Luca
    Fischerova, Daniela
    Froyman, Wouter
    Wynants, Laure
    Van Holsbeke, Caroline
    Epstein, Elisabeth
    Franchi, Dorella
    Kaijser, Jeroen
    Czekierdowski, Artur
    Guerriero, Stefano
    Fruscio, Robert
    Leone, Francesco P. G.
    Rossi, Alberto
    Landolfo, Chiara
    Vergote, Ignace
    Bourne, Tom
    Valentin, Lil
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (04) : 424 - 437
  • [9] Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses
    Auekitrungrueng, Rapeepat
    Tinnangwattana, Dangcheewan
    Tantipalakorn, Charuwan
    Charoenratana, Cholaros
    Lerthiranwong, Thitikarn
    Wanapirak, Chanane
    Tongsong, Theera
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 364 - 369
  • [10] Comparison of Pelvic Masses Score (PMS) and Risk of Malignancy Index (RMI 3) in the evaluation of pelvic masses
    Rossi, A.
    Forzano, L.
    Romanello, I.
    Ambrosini, G.
    Iuri, V.
    Marchesoni, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (04) : 421 - 424